anemia
Anemia refers to a condition in which the red blood cell count, hemoglobin content, and hematocrit in a certain volume of circulating blood are all lower than normal standards. Among them, hemoglobin is the most important. If it is lower than 120g/L (12.0g/dl) in adult males and lower than 110g/L (11.0/dl) in adult females, it is generally considered anemia. Anemia is one of the most common clinical manifestations, but it is not an independent disease. It may be an important clinical manifestation of a basic or sometimes more complex disease. Once anemia is found, its cause must be identified. Anemia caused by different reasons includes iron deficiency anemia, hemolytic anemia, megaloblastic anemia, aplastic anemia, thalassemia, sickle cell anemia, congenital dyserythropoietic anemia, sideroblastic anemia, and myelophthisis anemia. Acute and chronic anemia: anemia caused by acute blood loss, chronic anemia (such as rheumatic anemia, anemia caused by infectious diseases, anemia caused by hypothyroidism, anemia caused by liver disease, chronic renal anemia, anemia caused by malignant tumors, etc.).
-
Site of disease:
whole body
-
Infectious :
Not contagious
-
Frequent population:
All people, mainly women, elderly...
-
Related symptoms:
Fatigue
pale skin
loss of appetite
pale or pale conjunctiva
pale lips
-
Concurrent disease:
Related Drugs
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Zhongkai Biopharmaceutical Factory
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
NCPC Genetech BIOTECHNOLOGY Co., Ltd.
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
Chengdu Institute of Biological Products Co., Ltd.
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.